ADHD treatment co Alcobra raises $26m on Nasdaq

The company plans a second Phase III trial in the US for ADHD,drawing lessons from the previous Phase III trial.

from Content Keyword RSS http://ift.tt/1AErywD http://ift.tt/eA8V8J

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s